BRCA1 and cancer: Future research could improve data on psychological morbidity in cancer-unaffected BRCA1/2 pathogenic variant carriers by (1) using validated measures, (2) not conflating cancer-unaffected with cancer-affected carriers or cancer-unaffected carriers with the general population when reporting results, (3) reporting precisely how long carriers knew of their risk status when reporting results, and (4) diversifying the sample populations.